Aurora Sheboygan Prices – Caffeine Citrate 60 Milligrams Per 3 Milliliters Intravenous Solution Costs $80.24
Aurora Medical Center Sheboygan County provides a range of medical services, including the administration of intravenous solutions such as Caffeine Citrate. This particular medication, priced at $80.24 for a 60 milligrams per 3 milliliters intravenous solution, is used primarily in neonatal care to treat apnea of prematurity. Caffeine Citrate works by stimulating the central nervous system, helping to regulate breathing patterns in premature infants. The cost reflects the specialized nature of the medication and the precise care required in its administration.
What is Caffeine Citrate used for? – Caffeine Citrate is primarily used to treat apnea of prematurity in infants, which is a condition where premature babies experience pauses in breathing.
How is Caffeine Citrate administered? – It is administered intravenously, allowing for precise dosing and rapid absorption into the bloodstream.
Why does Caffeine Citrate cost $80.24? – The cost reflects the specialized formulation and the critical role it plays in neonatal care, as well as the resources required for its administration.
Is Caffeine Citrate safe for all infants? – While generally safe, its use is typically restricted to premature infants under medical supervision to ensure proper dosing and monitoring.
Can Caffeine Citrate be used for adults? – Caffeine Citrate is specifically formulated for neonatal use and is not typically used in adult treatments.
Are there any side effects associated with Caffeine Citrate? – Possible side effects include increased heart rate and gastrointestinal disturbances, which require monitoring by healthcare professionals.
How long does a treatment with Caffeine Citrate last? – The duration of treatment varies depending on the infant’s response and medical condition, with regular assessments by healthcare providers.
Is there an alternative to Caffeine Citrate? – Alternatives may exist, but Caffeine Citrate is often preferred due to its efficacy and safety profile in treating apnea of prematurity.
